Trial · NCT01329419
Adverse events73
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 73
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 6 | 4,158 | |
| other | Dyspepsia | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 5 | 4,158 | |
| other | Gagging | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 4 | 4,158 | |
| other | Flatulence | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 4 | 4,158 | |
| other | Diarrhea | General disorders | Hepsera 10 mg Once a Day | 2 | 4,158 | |
| other | Esophageal Varices | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 1 | 4,158 | |
| other | Hemorrhage Rectum | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 1 | 4,158 | |
| other | Gastric Ulcer Hemorrhagic | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 1 | 4,158 | |
| other | Hematemesis | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 1 | 4,158 | |
| other | Melaena | Gastrointestinal disorders | Hepsera 10 mg Once a Day | 1 | 4,158 | |
| other | Hepatic Failure | Hepatobiliary disorders | Hepsera 10 mg Once a Day | 9 | 4,158 | |
| other | Hepatic Cirrhosis | Hepatobiliary disorders | Hepsera 10 mg Once a Day | 4 | 4,158 | |
| other | Alanine Transaminase/Aspartate Aminotransferase Increased | Hepatobiliary disorders | Hepsera 10 mg Once a Day | 2 | 4,158 | |
| other | Hepatic Encephalopathy | Hepatobiliary disorders | Hepsera 10 mg Once a Day | 2 | 4,158 | |
| other | Hepatitis Chronic Active Aggrava | Hepatobiliary disorders | Hepsera 10 mg Once a Day | 2 | 4,158 | |
| other | Jaundice | Hepatobiliary disorders | Hepsera 10 mg Once a Day | 2 | 4,158 | |
| other | Asthenia | General disorders | Hepsera 10 mg Once a Day | 5 | 4,158 | |
| other | Ascites | General disorders | Hepsera 10 mg Once a Day | 3 | 4,158 | |
| other | Fatigue | General disorders | Hepsera 10 mg Once a Day | 3 | 4,158 | |
| other | Tolerance | General disorders | Hepsera 10 mg Once a Day | 1 | 4,158 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01329419/events